Literature DB >> 6400434

Increased incidence of lung metastases of sarcoma 276 bearing XVII/Berlin mice after total body irradiation and BCG.

W Arnold, A Graffi.   

Abstract

Combined prophylactic treatment by total body irradiation and BCG produce an increase in lung metastasis incidence and pleural effusions in a syngeneic murine tumor model. The prophylactic effect of BCG on metastasis formation is abolished independently of the order of pretreatments. Several possible causative mechanisms underlying this phenomenon and the clinical implications are discussed.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6400434     DOI： 10.1007/BF00121492

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN： 0262-0898            Impact factor:   5.150


  13 in total

1.  Demonstration of the stimulation of the reticulohistiocytic system (RHS) of mice by treatment with BCG by means of biometric and histochemical techniques.

Authors:  F Fey; W Arnold; A Graffi
Journal:  Eur J Cancer       Date:  1976-08       Impact factor: 9.162

Review 2.  Immunotherapy from malignant disease.

Authors:  J E Goodnight; D L Morton
Journal:  Annu Rev Med       Date:  1978       Impact factor: 13.739

3.  Prophylaxis of metastases formation by unspecific immunologic stimulation associated with heparintherapy.

Authors:  I Kiricuta; C Todorutiu; T Muresian; R Risca
Journal:  Cancer       Date:  1973-06       Impact factor: 6.860

4.  Sequential radiotherapy and adriamycin in the management of bronchogenic carcinoma: the question of additive toxicity.

Authors:  J C Ruckdeschel; D H Baxter; M F McKneally; D A Killam; S L Lunia; J Horton
Journal:  Int J Radiat Oncol Biol Phys       Date:  1979-08       Impact factor: 7.038

5.  Nicotinic acid production of BCG substrains in relationship to their residual virulence and immunogenic efficacy.

Authors:  A Zureck
Journal:  J Hyg Epidemiol Microbiol Immunol       Date:  1975

6.  Clinical experience with irradiation of inflammatory carcinoma of the breast with and without elective chemotherapy.

Authors:  J L Barker; E D Montague; L J Peters
Journal:  Cancer       Date:  1980-02-15       Impact factor: 6.860

7.  BCG in cancer immunotherapy: results obtained with various BCG preparations in a screening study for systemic adjuvants applicable to cancer immunoprophylaxis or immunotherapy.

Authors:  G Mathé; O Halle-Pannenko; C Bourut
Journal:  Natl Cancer Inst Monogr       Date:  1973-12

8.  Effectivity of living and non-living BCG vaccine on experimental metastatic spread in mice and the stimulation of the reticulohistiocytic system (RHS).

Authors:  W Arnold; F Fey; A Graffi
Journal:  Neoplasma       Date:  1981       Impact factor: 2.575

9.  Phase II study of adriamycin, 5-fluorouracil, levamisole, and irradiation in carcinoma of the bladder.

Authors:  F Lundbeck; I S Christophersen
Journal:  Cancer Treat Rep       Date:  1979-02

10.  Effect of BCG cell-wall skeleton immunotherapy on the peripheral blood lymphocytes in patients with lung cancer after radiotherapy.

Authors:  H Nishikawa; S Yasaki; T Yoshimoto; M Sakatani; M Itoh; T Masuno; M Namba; T Ogura; F Hirao; I Azuma; Y Yamamura
Journal:  Gan       Date:  1978-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.